CymaBay Announces Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
CymaBay Therapeutics (CBAY) Tops Q3 EPS by 6c
November 12, 2015 4:29 PM ESTCymaBay Therapeutics (NASDAQ: CBAY) reported Q3 EPS of ($0.27), $0.06 better than the analyst estimate of ($0.33).
For earnings history and earnings-related data on CymaBay Therapeutics (CBAY) click here.
... More


